91
Views
3
CrossRef citations to date
0
Altmetric
Original Research

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

, , , , , , , , & show all
Pages 1643-1649 | Published online: 06 Jul 2015

References

  • ParkinDMBrayFFerlayJPisaniPEstimating the world cancer burden: Globocan 2000Int J Cancer200194215315611668491
  • KristensenVNDivide and conquer: the genetic basis of molecular subclassification of breast cancerEMBO Mol Med20113418318521394915
  • MaireVNématiFRichardsonMPolo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancerCancer Res201373281382323144294
  • AndersCKCareyLABiology, metastatic patterns, and treatment of patients with triple-negative breast cancerClin Breast Cancer20099Suppl 2S73S8119596646
  • ForrestRASwiftLPEvisonBJThe hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adductsCancer Chemother Pharmacol201371380981623263186
  • HofmannKUbiquitin-binding domains and their role in the DNA damage responseDNA Repair (Amst)20098454455619213613
  • BatesEERavelODieuMCIdentification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cellsEur J Immunol19972710247124779368598
  • EdgeSBByrdDRComptonCCFritzAGGreeneFLTrottiAAJCC cancer staging manual7th edNew York, NYSpringer2010
  • ToriolaATColditzGATrends in breast cancer incidence and mortality in the United States: implications for preventionBreast Cancer Res Treat2013138366567323546552
  • PujolHTrends in breast cancer incidence, survival, and mortalityLancet20003569229591952 author reply 59310950253
  • JoergerMEssSDehlerSA population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancerSwiss Med Wkly2012142w1357122495767
  • GyémántNTanakaMAntusSIn vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cellsIn Vivo200519236737415796199
  • LeeCGRenJCheongISExpression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancersOncogene200322172592260312730673
  • LiuLDongZLiangJAs an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathwayOncogene201433790992023812429
  • GongPCanaanAWangBThe ubiquitin-like protein FAT10 mediates NF-kappaB activationJ Am Soc Nephrol201021231632619959714
  • YuanRWangKHuJUbiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradationCancer Res201474185287530025056121